Bonk (BNKK) risk factors, FY2025 10-K

Risks Related to Our BONK Holdings and Treasury Strategy

1. 01The BONK token is a highly volatile asset, and fluctuations in the price of the BONK token are likely to affect our financial results and the market price of our listed securitiesNew
2. 02The BONK token and other digital assets are novel assets, and are subject to significant legal, commercial, regulatory and technical uncertaintyNew
3. 03A significant decrease in the market value of our BONK token holdings could adversely affect our ability to satisfy our financial obligationsNew
4. 04Our historical financial statements do not reflect the potential variability in earnings that we may experience in the future relating to our BONK token holdingsNew
5. 05Our BONK treasury strategy subjects us to enhanced regulatory oversightNew
6. 06In addition, private actors that are wary of the BONK token or the regulatory concerns associated with the BONK token have in the past taken and may in the future take further actions that may have an adverse effect on our business or the market price of our listed securitiesNew
7. 07The concentration of our BONK token holdings enhances the risks inherent in our BONK treasury strategyNew
8. 08As a result of our BONK treasury strategy, our assets are concentrated in our BONK token holdings. Accordingly, the emergence or growth of digital assets other than the BONK token (such as Bitcoin and Ethereum) may have a material adverse effect on our financial conditionNew
9. 09Our BONK token holdings are less liquid than our existing cash and cash equivalents and may not be able to serve as a source of liquidity for us to the same extent as cash and cash equivalentsNew
10. 10We face risks relating to the security of the wallets holding our BONK tokens, including the loss or destruction of private keys required to access our BONK tokens and cyberattacks or other data loss relating to our BONK tokensNew
11. 11significant regulatory scrutiny, investigations, fines, penalties, and other legal, regulatory, contractual and financial exposureNew
12. 12Absent federal regulations, there is a possibility that the BONK token may be classified as a “security.” Any classification of the BONK token as a “security” would subject us to additional regulation and could materially impact the operation of our businessNew
13. 13We are not subject to legal and regulatory obligations that apply to investment companies such as mutual funds and exchange-traded funds, or to obligations applicable to investment advisersNew
14. 14Our BONK treasury strategy exposes us to risk of non-performance by counterpartiesNew
15. 15If we are unable to keep up with rapid technological changes, our products may become obsolete
16. 16Competition could adversely affect our business
17. 17If we are unable to develop and maintain our brand and reputation for our product offerings, our business and prospects could be materially harmed
18. 18We are subject to government regulation, and unfavorable changes could substantially harm our business and results of operations
19. 19We depend heavily on key personnel, and turnover of key senior management could harm our business
20. 20Our products may not meet health and safety standards or could become contaminated
21. 21The sale of our products involves product liability and related risks that could expose us to significant insurance and loss expenses
22. 22The success of our business will depend upon our ability to create and expand our brand awareness
23. 23We must develop and introduce new products to succeed
24. 24Adverse publicity associated with our products or ingredients, or those of similar companies, could adversely affect our sales and revenue
25. 25If serious adverse or undesirable side effects are identified during the development of our product candidates, we may abandon or limit our development or commercialization of such product candidates77% rewritten
26. 26If we experience delays or difficulties in the enrollment of subjects to our clinical trials, our ability to complete such trials will be adversely affectedNew
27. 27It is uncertain whether product liability insurance will be adequate to address product liability claims, or that insurance against such claims will be affordable or available on acceptable terms in the future
28. 28If we are unable to establish relationships with licensees or collaborators to carry out sales, marketing, and distribution functions or to create effective marketing, sales, and distribution capabilities, we will be unable to market our products successfully
29. 29Natural disasters and other events beyond our control could materially adversely affect us
30. 30We have a limited operating history upon which investors can evaluate our future prospects
31. 31We are subject to government regulations of the processing, formulation, packaging, labeling and advertising of our wellness and dietary supplement products
32. 32Our failure to comply with applicable laws or regulations could result in substantial monetary penalties and could adversely affect our operating results
33. 33Our reliance on third parties to manufacture and supply our products, including the Sure Shot Dietary Supplement and Yerbaé’s plant-based beverages, may harm our business, financial condition and operating results
34. 34We may not meet our product development and commercialization milestones
35. 35Our operations in international markets involve inherent risks that we may not be able to control
36. 36Compliance with new and existing laws and governmental regulations could increase our costs significantly and adversely affect our results of operations
37. 37International trade disputes, including U.S. trade tariffs and retaliatory tariffs, could adversely impact our business
38. 38Significant political, trade, regulatory developments, and other circumstances beyond our control, could have a material adverse effect on our financial condition or results of operations
39. 39Regulatory changes or actions may alter the nature of an investment in us or restrict the use of cryptocurrencies in a manner that adversely affects our business, prospects, or operations
40. 40Our business, operations, financial position and timelines, could be materially adversely affected by the continuing military action in Ukraine and the war between Israel and Hamas

Risks Related to our Financial Position and Capital Needs

1. 41Our accountant has indicated doubt about our ability to continue as a going concern
2. 42Raising additional capital may cause dilution to our existing stockholders, restrict our operations or require us to relinquish rights to our technologies or other assets
3. 43Changes in tax laws and unanticipated tax liabilities could adversely affect our effective income tax rate and ability to achieve profitability

Risks Related to our Intellectual Property

1. 44We may incur substantial costs as a result of litigation or other proceedings relating to patent and other intellectual property rights
2. 45A third party may sue us or one of our strategic collaborators for infringing its intellectual property rights. Likewise, we may need to resort to litigation to enforce licensed rights or to determine the scope and validity of third-party intellectual property rights
3. 46Any inability to protect our intellectual property rights could reduce the value of our products and brands, which could adversely affect our financial condition, results of operations and business
4. 47The intellectual property behind our products may include unpublished know-how as well as existing and pending intellectual property protection. All intellectual property protection eventually expires, and unpublished know-how is dependent on key individuals
5. 48If we are not able to adequately protect our intellectual property, then we may not be able to compete effectively, and we may not be profitable

Risks Related to Our Securities and Other Risks

1. 49We are an “emerging growth company” and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors
2. 50We have broad discretion in the use of the net proceeds from any offerings and may not use them effectively
3. 51Our management has limited experience in managing the day-to-day operations of a public company and, as a result, we may incur additional expenses associated with the management of our Company
4. 52Compliance with changing corporate governance regulations and public disclosures may result in additional risks and exposures
5. 53Certain of our stockholders hold a significant percentage of our outstanding voting securities, which could reduce the ability of minority stockholders to effect certain corporate actions
6. 54If securities or industry analysts publish inaccurate or unfavorable research about our business, our stock price could decline44% rewritten
7. 55We do not intend to pay dividends for the foreseeable futureNew
8. 56Our Second Amended and Restated Certificate of Incorporation contains an exclusive forum provision for certain claims, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees
9. 57Our issuance of additional common stock or preferred stock may cause our common stock price to decline, which may negatively impact your investment
10. 58Anti-takeover provisions in the Company’s charter and bylaws may prevent or frustrate attempts by stockholders to change the board of directors or current management and could make a third-party acquisition of the Company difficult
11. 59Our common stock may become subject to the SEC’s penny stock rules and accordingly, broker-dealers may experience difficulty in completing customer transactions and trading activity in our securities may be adversely affected